Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Article Title: Brain and cognitive functions in two groups of na夫e HIV patients selected for a different plan of antiretroviral therapy: A qEEG study.
PMID/MRN: 27716535
Publication Date: 2016-Nov-27
Abstract:
Cortical sources of electroencephalographic (EEG) rhythms were investigated in two sub-populations of na夫e HIV subjects, grouped based on clinical criteria to receive different combination anti-retroviral therapies (cARTs). These EEG sources were hypothesized to reflect beneficial effects of both regimes.
Eyes-closed resting state EEG data were collected in 19 (Group A) and 39 (Group B) na夫e HIV subjects at baseline (i.e. pre-treatment; T0) and after 5months of cART (T5). Compared with the Group A, the Group B was characterized by slightly worse serological parameters and higher cardiovascular risk. At T0, mean viral load (VL) and CD4 count were 87,694copies/ml and 435cells/?l in the Group A and 187,370copies/ml and 331cells/?l in the Group B. The EEG data were also collected in 50 matched control HIV-negative subjects. Cortical EEG sources were assessed by LORETA software.
Compared to the Control Group, the HIV Groups showed lower alpha (8-12Hz) source activity at T0 while the Group B also exhibited higher delta source activity. The treatment partially normalized alpha and delta source activity in the Group A and B, respectively, in association with improved VL, CD4, and cognitive functions.
Different cART regimens induced diverse beneficial effects in delta or alpha source activity in the two na夫e HIV Groups.
These sources might unveil different neurophysiological effects of diverse cART on brain function in na夫e HIV Groups as a function of clinical status and/or therapeutic compounds.
Copyright ゥ 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.